John discusses the future of medical cannabis with a particular focus on the interconnectability of patient monitoring and data collection as it relates to the translation of the data to cutting edge pharmaceutical research and development.
John Vavalo is the founder and CEO of Terradiol, a highly diverse biopharmaceutical company headquartered in Syracuse, New York. Terradiol is focused on creating real social impact through collaboration with states where medical cannabis has been legalized and is deeply committed to changing the future of cannabinoid medicine through cutting edge research and development.
At Terradiol, John is the driving force behind the culture and vision of the company. Since inception, John’s focus for Terradiol has been to build a world class pharmaceutical company to cultivate, process and dispense pharmaceutical grade cannabis based medicines. John’s personal expertise in process mapping and extraction gives Terradiol an additional competitive edge in a complex marketplace.
In addition to founding Terradiol, John was a founding member of New York Canna, a medical cannabis company created to operate in the State of New York. After being a top finisher in NY, John and his partners are well p
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx